{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc388" }, "patient_id" : "YwSN7SjqLrTcJ4jW7", "patient_label" : "DTB-134", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 69, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.554-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-134", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-134Pro", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Goserelin", "reason_for_stop" : "Other", "start_day" : -2060, "end_day" : -1136 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Completed Treatment", "start_day" : -2060, "end_day" : -2019 }, { "drug_name" : "Degarelix", "reason_for_stop" : "Other", "start_day" : -1134 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -303, "end_day" : -3 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -303, "end_day" : -7 }, { "drug_name" : "Enzalutamide", "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 10 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc389" }, "patient_id" : "E2FKuv7XFLYR6QsFG", "patient_label" : "DTB-135", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 57, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.558-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-135", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-135Pro", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -182, "end_day" : -161 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -50, "end_day" : -16 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -175 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 6, "end_day" : 76 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc38a" }, "patient_id" : "Ws2F9sT2CJWsQ7GgZ", "patient_label" : "DTB-149", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 70, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.561-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-149", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -183, "end_day" : -79 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -573 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 6 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc38b" }, "patient_id" : "mhc4BYwQ8bHKCHX8z", "patient_label" : "DTB-150", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 68, "race" : "Asian", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.563-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-150", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Degarelix", "reason_for_stop" : "Other", "start_day" : -591, "end_day" : -557 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -536 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -536, "end_day" : -560 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -175, "end_day" : 1 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc38c" }, "patient_id" : "QmcW7BKTWg86fTSNs", "patient_label" : "DTB-151", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 72, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.566-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-151", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4446, "end_day" : -793 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4446, "end_day" : -793 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -216, "end_day" : -216 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -793 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 14 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc38d" }, "patient_id" : "2BHsjFofkyijh9iRc", "patient_label" : "DTB-153", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 78, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.568-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-153", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -7360 }, { "drug_name" : "Zoladex;  Flutamide", "reason_for_stop" : "Completed Treatment", "start_day" : -7360, "end_day" : -6629 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -1942, "end_day" : -1516 }, { "drug_name" : "XGEVA", "reason_for_stop" : "Adverse Event", "start_day" : -1243, "end_day" : -1243 }, { "drug_name" : "TAK-700", "reason_for_stop" : "Adverse Event", "start_day" : 18, "end_day" : -1091 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1077 }, { "drug_name" : "XGEVA", "reason_for_stop" : { "$undefined" : true }, "start_day" : -770 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : "Completed Treatment", "start_day" : -362, "end_day" : -335 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -331 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc38e" }, "patient_id" : "PR5h2CdRKwT43F4ew", "patient_label" : "DTB-154", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 78, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.570-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-154", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -738, "end_day" : -463 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1559 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1651, "end_day" : -2655 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc38f" }, "patient_id" : "MkKjGQXs5wBF2u3Hy", "patient_label" : "DTB-155", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 63, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.572-0700" }, "is_on_study" : true, "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1102 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -791 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "end_day" : -474 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -264, "end_day" : -281 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -264 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc390" }, "patient_id" : "bRErqopLjhi8EW98v", "patient_label" : "DTB-156", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 71, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.576-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-156", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -651, "end_day" : -436 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "end_day" : -1 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 1 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc391" }, "patient_id" : "mvnYvQ4Xe4MQthWs3", "patient_label" : "DTB-157", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 59, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.578-0700" }, "is_on_study" : true }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc392" }, "patient_id" : "3urrrrJmXJsG7Ao7R", "patient_label" : "DTB-158", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 72, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.580-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-158", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2288, "end_day" : -2107 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1468, "end_day" : -737 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -196, "end_day" : 5 }, { "drug_name" : "XGEVA", "reason_for_stop" : { "$undefined" : true }, "start_day" : -72 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -737 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -2288, "end_day" : -2107 }, { "drug_name" : "Placebo;  ARN-509", "reason_for_stop" : "Progressive Disease", "start_day" : -359, "end_day" : -245 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 7 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc393" }, "patient_id" : "CEvjHMJqWhfTuchgf", "patient_label" : "DTB-159", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 79, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.583-0700" }, "is_on_study" : true, "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 8 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc394" }, "patient_id" : "RqDwrkkFbfbHd9w5w", "patient_label" : "DTB-160", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 87, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.585-0700" }, "is_on_study" : true, "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc395" }, "patient_id" : "oDKpdHBSs4LTaykFC", "patient_label" : "DTB-086", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 72, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.587-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-086", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -258, "end_day" : 1 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -325, "end_day" : -270 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -806 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 0, "end_day" : 57 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc396" }, "patient_id" : "qfPKdFYw32ow3MSeq", "patient_label" : "DTB-088", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 73, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.590-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-088", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "end_day" : -30 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -837 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "0%-30%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 6, "end_day" : 89 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc397" }, "patient_id" : "nAq2SYn5pgHuQZpNw", "patient_label" : "DTB-089", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 79, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.592-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-089", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] }, { "sample_label" : "DTB-089Pro", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -996 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -837, "end_day" : -548 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -548, "end_day" : -27 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -2625, "end_day" : -2576 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1661, "end_day" : -1416 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1689, "end_day" : -1416 }, { "drug_name" : "Dutasteride", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1388, "end_day" : -1016 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1010, "end_day" : -990 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 7, "end_day" : 89 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc398" }, "patient_id" : "KzgNEkHYrJWujQYJD", "patient_label" : "DTB-090", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 45, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.594-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-090", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Xofigo", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "PR", "reason_for_stop" : "Completed Treatment", "start_day" : 7, "end_day" : 149 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "PR", "reason_for_stop" : "Progressive Disease", "start_day" : -209, "end_day" : 260 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc399" }, "patient_id" : "Q3MFPFwKPft7btvAA", "patient_label" : "DTB-091", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 79, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.596-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-091", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Degarelix", "reason_for_stop" : "Patient Choice", "start_day" : -325, "end_day" : -269 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -150, "end_day" : -52 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -241 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 5, "end_day" : 81 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc39a" }, "patient_id" : "tCP4iD7z6EFbKhZLw", "patient_label" : "DTB-097", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 73, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.599-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-097", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-097Pro", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1353 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -179, "end_day" : -117 }, { "drug_name" : "Casodex", "reason_for_stop" : "Adverse Event", "start_day" : -1366, "end_day" : -1366 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -30, "end_day" : 5 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -96, "end_day" : 5 }, { "drug_name" : "BMN-673", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "PR", "reason_for_stop" : "Progressive Disease", "start_day" : 13, "end_day" : 239 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc39b" }, "patient_id" : "N6mtX5JkEHfBmzhZP", "patient_label" : "DTB-101", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 74, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.601-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-101", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Progressive Disease", "start_day" : -2647 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -2360, "end_day" : -2367 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -2450, "end_day" : -2459 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1881 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1789, "end_day" : -2001 }, { "drug_name" : "Docetaxel;  Carboplatin", "reason_for_stop" : "Patient Choice", "start_day" : -1702, "end_day" : -1576 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -747, "end_day" : 58 }, { "drug_name" : "Carboplatin;  Docetaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1282, "end_day" : -1154 }, { "drug_name" : "Docetaxel;  Carboplatin", "reason_for_stop" : "Adverse Event", "start_day" : -1499, "end_day" : -1331 }, { "drug_name" : "Xofigo", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : 148, "end_day" : 287 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 91, "end_day" : 135 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc39c" }, "patient_id" : "6nHuWKgiM6q7XrwRY", "patient_label" : "DTB-103", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 67, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.603-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-103", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-103Pro", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -2225, "end_day" : -2205 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1280, "end_day" : -1141 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1119 }, { "drug_name" : "Lupron", "reason_for_stop" : "Completed Treatment", "start_day" : -3095, "end_day" : -2730 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 9, "end_day" : 161 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc39d" }, "patient_id" : "FD4senrxLM7nfD85r", "patient_label" : "DTB-105", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 63, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.605-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-105", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-105Pro", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4624, "end_day" : -4259 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -893 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -914, "end_day" : -679 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3764, "end_day" : -3436 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3800, "end_day" : -3436 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4532, "end_day" : -4624 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -305, "end_day" : 1 }, { "drug_name" : "Cabazitaxel;  Mitoxantrone", "reason_for_stop" : "Adverse Event", "start_day" : -571, "end_day" : -376 }, { "drug_name" : "Xofigo", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Adverse Event", "start_day" : 15, "end_day" : 71 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Adverse Event", "start_day" : 130, "end_day" : 154 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc39e" }, "patient_id" : "ySjnWFKPerxous9QT", "patient_label" : "DTB-108", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 63, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.607-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-108", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Enzalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -141, "end_day" : 55 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -495, "end_day" : -141 }, { "drug_name" : "Lupron;  Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1530, "end_day" : -768 }, { "drug_name" : "Lupron;  Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2276, "end_day" : -2168 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -579, "end_day" : -538 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -495 }, { "drug_name" : { "$undefined" : true }, "category" : "SOC", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Adverse Event", "start_day" : 92, "end_day" : 140 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Physician Discretion", "start_day" : 160, "end_day" : 223 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc39f" }, "patient_id" : "gRGvTx6Rz2xfcBRx4", "patient_label" : "DTB-109", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 61, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.609-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-109", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -502, "end_day" : 1 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1323, "end_day" : -806 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1323 }, { "drug_name" : "Taxotere", "reason_for_stop" : { "$undefined" : true }, "start_day" : -615, "end_day" : -502 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -615, "end_day" : 10 }, { "drug_name" : "Sipuleucel-T", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment", "start_day" : 8, "end_day" : 51 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a0" }, "patient_id" : "iZBe5MQQJrb9gEgWo", "patient_label" : "DTB-110", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 66, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.611-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-110", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Other", "start_day" : -1657, "end_day" : -927 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -183 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -47, "end_day" : -357 }, { "drug_name" : "Lupron", "reason_for_stop" : "Other", "start_day" : -777 }, { "drug_name" : "Finasteride", "reason_for_stop" : "Other", "start_day" : -1657 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a1" }, "patient_id" : "BgtMJnZQwG8vjyhSK", "patient_label" : "DTB-111", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 69, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.615-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-111", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-111Pro", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Physician Discretion", "start_day" : -2075, "end_day" : -1893 }, { "drug_name" : "Lupron", "reason_for_stop" : "Completed Treatment", "start_day" : -1403, "end_day" : -1204 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -1403, "end_day" : -1114 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -938 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -780, "end_day" : -751 }, { "drug_name" : "Casodex", "reason_for_stop" : "Physician Discretion", "start_day" : -938, "end_day" : -850 }, { "drug_name" : "Casodex;  Panobinostat", "reason_for_stop" : "Progressive Disease", "start_day" : -696, "end_day" : -464 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -408, "end_day" : -16 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 6, "end_day" : 138 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a2" }, "patient_id" : "3zLuQWirS2HYxvkgB", "patient_label" : "DTB-112", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 76, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.618-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-112", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -4343, "end_day" : -3975 }, { "drug_name" : "Flutamide", "reason_for_stop" : "Completed Treatment", "start_day" : -4350, "end_day" : -4323 }, { "drug_name" : "Leuprolide", "reason_for_stop" : "Other", "start_day" : -3751, "end_day" : -2950 }, { "drug_name" : "Flutamide", "reason_for_stop" : "Other", "start_day" : -3421, "end_day" : -3239 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -2279, "end_day" : -2118 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Other", "start_day" : -2328, "end_day" : -2279 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -3238, "end_day" : -2426 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -2076, "end_day" : -109 }, { "drug_name" : "Pazopanib", "reason_for_stop" : "Progressive Disease", "start_day" : -2076, "end_day" : -474 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -334, "end_day" : 10 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -2866 }, { "drug_name" : "Enzalutamide", "category" : { "$undefined" : true }, "psa_response" : "0%-30%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 21 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a3" }, "patient_id" : "Am48cg6RKzRhiwDFB", "patient_label" : "DTB-113", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 70, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.619-0700" }, "is_on_study" : true, "treatments" : [ { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -183, "end_day" : 211 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a4" }, "patient_id" : "pj5vhx2fCMmfPbbqB", "patient_label" : "DTB-114", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 76, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.621-0700" }, "is_on_study" : false, "treatments" : [ { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Patient Demise", "start_day" : 13, "end_day" : 94 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a5" }, "patient_id" : "c9t8tDCZ7kCRckxdr", "patient_label" : "DTB-115", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 61, "race" : "American Indian or Alaska Native", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.623-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-115", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -190, "end_day" : -93 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -574 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 19 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a6" }, "patient_id" : "uoXwMt28nCbSqL7iE", "patient_label" : "DTB-116", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 68, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.625-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-116", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 21, "end_day" : 126 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a7" }, "patient_id" : "EQkr63NbgTgS5vZkA", "patient_label" : "DTB-117", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 82, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.627-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-117", "site_of_metastasis" : "Lung", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : "Physician Discretion", "start_day" : -1288, "end_day" : -1111 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : "Completed Treatment", "start_day" : -985, "end_day" : -957 }, { "drug_name" : "ARN-509", "reason_for_stop" : "Patient Choice", "start_day" : -866, "end_day" : -369 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -278, "end_day" : -173 }, { "drug_name" : "GM-CSF", "reason_for_stop" : "Progressive Disease", "start_day" : -172, "end_day" : -12 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1111 }, { "drug_name" : "Docetaxel;  Dexamethasone", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Adverse Event", "start_day" : 2, "end_day" : 44 }, { "drug_name" : "Dexamethasone", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 53 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a8" }, "patient_id" : "ftK8ZKrsLZH6gD6Bt", "patient_label" : "DTB-118", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 73, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.629-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-118", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -254, "end_day" : -1090 }, { "drug_name" : "Lupron", "reason_for_stop" : "Progressive Disease", "start_day" : -1350 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Completed Treatment", "start_day" : -1029, "end_day" : -877 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -595, "end_day" : -86 }, { "drug_name" : "Buparlisib", "reason_for_stop" : "Progressive Disease", "start_day" : -196, "end_day" : -86 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -86, "end_day" : -24 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 18, "end_day" : 61 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3a9" }, "patient_id" : "NzweJdJ6xSuNHfRXs", "patient_label" : "DTB-119", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 71, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.630-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-119", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 52 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3aa" }, "patient_id" : "br4EXcDLYstZEAJf2", "patient_label" : "DTB-120", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 64, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.632-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-120", "site_of_metastasis" : "Lung", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -395 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -419, "end_day" : -42 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ab" }, "patient_id" : "6gXJ4qbbaHLKttfvw", "patient_label" : "DTB-121", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 90, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.634-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-121", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -158, "end_day" : 42 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -735, "end_day" : -247 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -9409 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ac" }, "patient_id" : "P4dHkzdLafXykHETS", "patient_label" : "DTB-122", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 72, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.636-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-122", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Zoladex", "reason_for_stop" : "Other", "start_day" : -1857, "end_day" : -1718 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -207, "end_day" : 5 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -350, "end_day" : -262 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -681, "end_day" : -350 }, { "drug_name" : "Lupron Depot", "reason_for_stop" : { "$undefined" : true }, "start_day" : -795 }, { "drug_name" : "Lupron Depot", "reason_for_stop" : "Physician Discretion", "start_day" : -1659, "end_day" : -1143 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -1804, "end_day" : -1642 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "0%-30%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 5, "end_day" : 108 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 115 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ad" }, "patient_id" : "zm2ZgmJuqrHYdycEv", "patient_label" : "DTB-123", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 88, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.638-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-123", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -6545 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -670, "end_day" : -32 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : { "$undefined" : true }, "start_day" : -367, "end_day" : -321 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 9 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ae" }, "patient_id" : "fqrsxDMxJJhLGgDDd", "patient_label" : "DTB-124", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 74, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.640-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-124", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Goserelin", "reason_for_stop" : { "$undefined" : true }, "start_day" : -391 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -398, "end_day" : -165 }, { "drug_name" : "Degarelix", "reason_for_stop" : "Completed Treatment", "start_day" : -763, "end_day" : -763 }, { "drug_name" : "Flutamide", "reason_for_stop" : "Adverse Event", "start_day" : -4883, "end_day" : -4820 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Physician Discretion", "start_day" : -5002, "end_day" : -398 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -5009, "end_day" : -241 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -131 }, { "drug_name" : "Docetaxel", "category" : { "$undefined" : true }, "psa_response" : "0%-30%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 42, "end_day" : 169 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3af" }, "patient_id" : "39tQqGZZecXpcrNdD", "patient_label" : "DTB-125", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 65, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.642-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-125", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Other", "start_day" : -5785, "end_day" : -5785 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -5729, "end_day" : -5729 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -82, "end_day" : -2 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -5785 }, { "drug_name" : "Docetaxel", "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b0" }, "patient_id" : "xt8hzcPTKa3xzBiKY", "patient_label" : "DTB-126", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 90, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.644-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-126", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -62 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -62 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -283, "end_day" : -62 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -516, "end_day" : -488 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -516 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -6703, "end_day" : -6703 }, { "drug_name" : { "$undefined" : true }, "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -6703, "end_day" : -6703 }, { "drug_name" : "Lupron", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -516 }, { "drug_name" : "Casodex", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -516, "end_day" : -488 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : -283, "end_day" : -62 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : -62 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b1" }, "patient_id" : "X28WFs9k76jB4WtPt", "patient_label" : "DTB-127", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 72, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.645-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-127", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "end_day" : -640 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -640, "end_day" : -469 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -168, "end_day" : 0 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -265, "end_day" : -168 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1202 }, { "drug_name" : "Lupron", "reason_for_stop" : "Other", "start_day" : -1540, "end_day" : -1301 }, { "drug_name" : "Lupron", "reason_for_stop" : "Other", "start_day" : -2620, "end_day" : -2132 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Other", "start_day" : 1, "end_day" : 15 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 91 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b2" }, "patient_id" : "AReSwk7qAoJf7cPvg", "patient_label" : "DTB-128", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 78, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.647-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-128", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -265 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -273, "end_day" : -84 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 5 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b3" }, "patient_id" : "tdRECCPeJXeDHEuts", "patient_label" : "DTB-129", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 66, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.650-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-129", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -2872, "end_day" : -2872 }, { "drug_name" : "Degarelix", "reason_for_stop" : { "$undefined" : true }, "start_day" : -470, "end_day" : -441 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -441 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 6 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b4" }, "patient_id" : "Buoz57wSPa8J7aaaJ", "patient_label" : "DTB-130", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 65, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.653-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-130", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Provenge", "reason_for_stop" : "Progressive Disease", "start_day" : -131, "end_day" : -117 }, { "drug_name" : "Lupron;  Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2232, "end_day" : -352 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3526, "end_day" : -2819 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -105, "end_day" : 1 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -105 }, { "drug_name" : "Fluorouracil; Leucovorin; Oxaliplatin (FOLFOX)", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 27 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 122, "end_day" : 153 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b5" }, "patient_id" : "SAKEKwAHRGfGFx7nw", "patient_label" : "DTB-131", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 63, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.656-0700" }, "is_on_study" : true, "treatments" : [ { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 0 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b6" }, "patient_id" : "QcoyHbE9r5xyqYnfo", "patient_label" : "DTB-132", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 83, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.658-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-132", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -2512, "end_day" : -2421 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2526, "end_day" : -2469 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -255 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1722, "end_day" : -1501 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true }, "start_day" : 2 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b7" }, "patient_id" : "cdjpiYgitsH5efEAQ", "patient_label" : "DTB-133", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 65, "race" : "White; Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.660-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-133", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -102, "end_day" : -20 }, { "drug_name" : "Xofigo", "reason_for_stop" : { "$undefined" : true }, "start_day" : -246, "end_day" : -106 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -604 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Patient Choice", "start_day" : -725, "end_day" : -124 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -986, "end_day" : -2 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1128, "end_day" : -1098 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1251 }, { "drug_name" : "Nilutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1401, "end_day" : -1251 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1828, "end_day" : -1401 }, { "drug_name" : "Cyclophosphamide;  GM-CSF", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2193 }, { "drug_name" : "Docetaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2376, "end_day" : -2376 }, { "drug_name" : "Dutasteride;  Bicalutamide;  Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2528, "end_day" : -2193 }, { "drug_name" : "Selinexor", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 34 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b8" }, "patient_id" : "sJp9QJsh8XLcuagrz", "patient_label" : "DTB-136", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 79, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.662-0700" }, "is_on_study" : true, "treatments" : [ { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -116 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3b9" }, "patient_id" : "C9CKfnSaPuRgdD6g3", "patient_label" : "DTB-137", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 61, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.664-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-137", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Degarelix", "reason_for_stop" : { "$undefined" : true }, "start_day" : -328, "end_day" : -299 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -306, "end_day" : -292 }, { "drug_name" : "Lupron Depot", "reason_for_stop" : { "$undefined" : true }, "start_day" : -299 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 13 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ba" }, "patient_id" : "MyJCqb6JueS4NKj5p", "patient_label" : "DTB-138", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 78, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.666-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-138", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Leuprolide", "reason_for_stop" : "Patient Choice", "start_day" : -2483, "end_day" : -2124 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Patient Choice", "start_day" : -2483, "end_day" : -2124 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1215 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -934, "end_day" : -468 }, { "drug_name" : "Flutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -419, "end_day" : -376 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -376, "end_day" : -335 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -257, "end_day" : 0 }, { "drug_name" : "Docetaxel", "category" : { "$undefined" : true }, "psa_response" : ">90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 11 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3bb" }, "patient_id" : "nHKERprwLJHDsoWds", "patient_label" : "DTB-139", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 68, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.668-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-139", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -320, "end_day" : 13 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1104, "end_day" : -321 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1315 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1434, "end_day" : -1104 }, { "drug_name" : "Leuprolide", "reason_for_stop" : "Other", "start_day" : -1419, "end_day" : -1315 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 13 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3bc" }, "patient_id" : "5p4wCcHtETzjWCAY6", "patient_label" : "DTB-141", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 71, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.669-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-141", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1012, "end_day" : -99 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1012 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 5 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3bd" }, "patient_id" : "QC6PSo8H4R8qHMBrK", "patient_label" : "DTB-142", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 71, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.672-0700" }, "is_on_study" : true, "treatments" : [ { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -194 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3be" }, "patient_id" : "u2qiZYmHtajEBdzyP", "patient_label" : "DTB-143", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 64, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.674-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-143", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2146, "end_day" : -1355 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -519 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 12 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3bf" }, "patient_id" : "nH4GjX64fbTvHhRer", "patient_label" : "DTB-144", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 71, "race" : "Asian", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.675-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-144", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Xofigo", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 52 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c0" }, "patient_id" : "tFMnShcrreCyjHvF5", "patient_label" : "DTB-145", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 70, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.677-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-145", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Flutamide", "reason_for_stop" : "Other", "start_day" : -498 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -142, "end_day" : -8 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -270, "end_day" : -142 }, { "drug_name" : "Leuprolide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -498 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -142 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c1" }, "patient_id" : "WWLrs6hxsvkqE2HqW", "patient_label" : "DTB-146", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 60, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.679-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-146", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1515, "end_day" : -1004 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1544 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -925, "end_day" : -745 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : "Completed Treatment", "start_day" : -918, "end_day" : -890 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -676 }, { "drug_name" : "Finasteride", "reason_for_stop" : { "$undefined" : true }, "end_day" : -1254 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -707, "end_day" : -660 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 54 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c2" }, "patient_id" : "Fmt2uHGWcnyvNRgkK", "patient_label" : "DTB-147", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 62, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.681-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-147", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -267, "end_day" : -2 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -531 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -531, "end_day" : -395 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : "Completed Treatment", "start_day" : -332, "end_day" : -304 }, { "drug_name" : "Cabazitaxel;  Mitoxantrone", "category" : "Clinical Trial", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 60 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c3" }, "patient_id" : "o6fybu3hruLCTuu23", "patient_label" : "DTB-148", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 67, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.683-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-148", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1546, "end_day" : -1324 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1560, "end_day" : -1512 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -187 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 2 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c4" }, "patient_id" : "Z5tTFTDLMo3TRuPB5", "patient_label" : "DTB-003", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 71, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.685-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-003", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3705 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3705, "end_day" : -3096 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -2762, "end_day" : 7 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 31, "end_day" : 77 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c5" }, "patient_id" : "CPzXNDq73uMeMzDMy", "patient_label" : "DTB-004", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 71, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.687-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-004", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Other", "start_day" : -5201, "end_day" : -2644 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2490 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -5201, "end_day" : -4714 }, { "drug_name" : "GM-CSF;  Hydrocortisone Sodium Succinate;  Ketoconazole", "reason_for_stop" : "Patient Choice", "start_day" : -3099, "end_day" : -2644 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1903, "end_day" : -1903 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -2245, "end_day" : -725 }, { "drug_name" : "Provenge", "reason_for_stop" : { "$undefined" : true }, "start_day" : -645, "end_day" : -607 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -538, "end_day" : -386 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -320, "end_day" : -264 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -4714, "end_day" : -3192 }, { "drug_name" : "Docetaxel;  Carboplatin", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Patient Choice", "start_day" : 6, "end_day" : 239 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c6" }, "patient_id" : "NyffqNr6MoG57McXe", "patient_label" : "DTB-005", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 60, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.689-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-005", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -205, "end_day" : -121 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -121 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -121, "end_day" : -58 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -23, "end_day" : -10 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : "PR", "reason_for_stop" : "Progressive Disease", "start_day" : 5, "end_day" : 115 }, { "drug_name" : "Carboplatin;  Docetaxel", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true }, "start_day" : 115, "end_day" : 136 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c7" }, "patient_id" : "ttBnYyQLwbuLNqPKy", "patient_label" : "DTB-007", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 61, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.691-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-007", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -110, "end_day" : -12 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -268, "end_day" : -200 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -756, "end_day" : -199 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -756 }, { "drug_name" : "Cabazitaxel;  Mitoxantrone", "category" : "Clinical Trial", "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Patient Choice", "start_day" : 37, "end_day" : 142 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c8" }, "patient_id" : "N66cijR8e7d7Gw5cJ", "patient_label" : "DTB-008", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 75, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.693-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-008", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -366, "end_day" : -173 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 8, "end_day" : 344 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 8, "end_day" : 427 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3c9" }, "patient_id" : "tkLdgeoXpvwQxFxHP", "patient_label" : "DTB-009", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 63, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.697-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-009", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -399, "end_day" : -134 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -368 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -107, "end_day" : 34 }, { "drug_name" : "Dexamethasone;  Docetaxel", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 75, "end_day" : 139 }, { "drug_name" : "Dexamethasone;  Docetaxel;  Carboplatin", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 160, "end_day" : 181 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ca" }, "patient_id" : "dCjDAFjed5qQGpdgJ", "patient_label" : "DTB-010", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 61, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.700-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-010", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "other" : [ { "hello" : true } ] } ], "pathways" : [] }, { "sample_label" : "DTB-010Pro", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 6, "end_day" : 66 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3cb" }, "patient_id" : "iXCR6nvxeZxnwCkQE", "patient_label" : "DTB-011", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 68, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.702-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-011", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1204, "end_day" : -139 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1730 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 11 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3cc" }, "patient_id" : "z2jzHYCDCDGaX9aHT", "patient_label" : "DTB-013", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 65, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.704-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-013", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1009, "end_day" : -228 }, { "drug_name" : "Lupron Depot", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2682 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -228, "end_day" : -200 }, { "drug_name" : "Casodex;  Panobinostat", "reason_for_stop" : "Other", "start_day" : -146, "end_day" : -126 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 1 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3cd" }, "patient_id" : "tEkM2t9Xp7ZPdnCHy", "patient_label" : "DTB-014", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 65, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.706-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-014", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-014Pro", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1346, "end_day" : -403 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -99 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -233, "end_day" : -99 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 5, "end_day" : 513 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ce" }, "patient_id" : "Fjiymw5jW4fz8fAn9", "patient_label" : "DTB-015", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 74, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.708-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-015", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -826 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -826, "end_day" : -465 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -339, "end_day" : -255 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -200, "end_day" : -165 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 12, "end_day" : 151 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3cf" }, "patient_id" : "EEpLEoAKPfhrq4EEW", "patient_label" : "DTB-016", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 69, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.710-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-016", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-016Pro", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -464 }, { "drug_name" : "Casodex", "reason_for_stop" : "Other", "start_day" : -472, "end_day" : -443 }, { "drug_name" : "Ipilimumab", "reason_for_stop" : "Adverse Event", "start_day" : -254, "end_day" : -212 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 12, "end_day" : 334 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d0" }, "patient_id" : "vKoSMRbpbEKWmvTDX", "patient_label" : "DTB-018", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 55, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.712-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-018", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1628, "end_day" : -1232 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1994 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1994, "end_day" : -1628 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -1166, "end_day" : -495 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3, "end_day" : 282 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d1" }, "patient_id" : "ETsaTSuLfbwXt4LXj", "patient_label" : "DTB-019", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 66, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.714-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-019", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-019Pro", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -559, "end_day" : -321 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : "Completed Treatment", "start_day" : -280, "end_day" : -249 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -229, "end_day" : -74 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 0, "end_day" : 168 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d2" }, "patient_id" : "Zc6gzmNF2e64kAHym", "patient_label" : "DTB-020", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 70, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.716-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-020", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1145, "end_day" : -560 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1145 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -464, "end_day" : -436 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -511, "end_day" : -259 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -259, "end_day" : -160 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -259, "end_day" : -160 }, { "drug_name" : "NRX 194204", "reason_for_stop" : "Progressive Disease", "start_day" : -160, "end_day" : -91 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -79, "end_day" : -4 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 0 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d3" }, "patient_id" : "WpkQr8GzNz7QTZggk", "patient_label" : "DTB-021", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 57, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.719-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-021", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1605, "end_day" : -74 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "PR", "reason_for_stop" : "Progressive Disease", "start_day" : 0, "end_day" : 531 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d4" }, "patient_id" : "g3uhZCvDD2H7u5Htz", "patient_label" : "DTB-022", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 69, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.721-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-022", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] }, { "sample_label" : "DTB-022Pro", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -345 }, { "drug_name" : "Ipilimumab", "reason_for_stop" : "Progressive Disease", "start_day" : -93, "end_day" : -30 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 6, "end_day" : 607 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 622 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d5" }, "patient_id" : "hKFZqgzxevZBNuDup", "patient_label" : "DTB-023", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 54, "race" : "Asian", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.723-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-023", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -1639, "end_day" : -871 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -871, "end_day" : -666 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -605, "end_day" : -605 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -617, "end_day" : -575 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -850 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -548, "end_day" : -373 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -373, "end_day" : -544 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -263 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -256 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -178, "end_day" : -178 }, { "drug_name" : "Xofigo", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 34 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d6" }, "patient_id" : "M74vEeYML494mthTi", "patient_label" : "DTB-024", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 77, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.725-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-024", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "other" : [ { "hello" : true } ] } ], "pathways" : [] }, { "sample_label" : "DTB-024Pro", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] }, { "sample_label" : "DTB-024Pro2", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -731 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -706, "end_day" : -700 }, { "drug_name" : "Panobinostat", "reason_for_stop" : "Progressive Disease", "start_day" : -286, "end_day" : -139 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -132, "end_day" : -13 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 17, "end_day" : 91 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 107, "end_day" : 267 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d7" }, "patient_id" : "4pKGzu8ycx3GbvT5x", "patient_label" : "DTB-025", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 74, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.727-0700" }, "is_on_study" : false, "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Physician Discretion", "start_day" : -6737, "end_day" : -6119 }, { "drug_name" : "Casodex", "reason_for_stop" : "Physician Discretion", "start_day" : -5641, "end_day" : -3115 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2476 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1745, "end_day" : -1684 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Physician Discretion", "start_day" : -1684, "end_day" : -1472 }, { "drug_name" : "Placebo", "reason_for_stop" : "Progressive Disease", "start_day" : -1199, "end_day" : -1077 }, { "drug_name" : "Hydrocortisone Sodium Succinate;  Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -1077, "end_day" : -376 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -376, "end_day" : -254 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -223, "end_day" : -11 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d8" }, "patient_id" : "iFCbQAFmYShpWFjfK", "patient_label" : "DTB-026", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 61, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.729-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-026", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-026Pro", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -319, "end_day" : -306 }, { "drug_name" : "Lupron;  Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -630, "end_day" : -438 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -342, "end_day" : 49 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -438 }, { "drug_name" : "Cabazitaxel;  Dexamethasone;  Mitoxantrone", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 86, "end_day" : 401 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3d9" }, "patient_id" : "oPGySrspCMnqYqDQw", "patient_label" : "DTB-027", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 72, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.731-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-027", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Leuprolide", "reason_for_stop" : "Progressive Disease", "start_day" : -831, "end_day" : -305 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -273, "end_day" : -140 }, { "drug_name" : "NRX 194204", "reason_for_stop" : "Progressive Disease", "start_day" : -112, "end_day" : 0 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -845, "end_day" : -305 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 30, "end_day" : 386 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3da" }, "patient_id" : "8Kd5rYwj8jyGcE27x", "patient_label" : "DTB-028", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 61, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.733-0700" }, "is_on_study" : false, "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -3029, "end_day" : -2907 }, { "drug_name" : "Lupron", "reason_for_stop" : "Progressive Disease", "start_day" : -3029, "end_day" : -7 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1507, "end_day" : -1173 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -1173, "end_day" : -1112 }, { "drug_name" : "Carboplatin; Etoposide", "reason_for_stop" : "Progressive Disease", "start_day" : -897, "end_day" : -777 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -777, "end_day" : -280 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -280, "end_day" : -98 }, { "drug_name" : "Taxotere", "reason_for_stop" : "Patient Choice", "start_day" : -98, "end_day" : -7 }, { "drug_name" : "Radium-223 chloride", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Physician Discretion", "start_day" : 16, "end_day" : 16 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3db" }, "patient_id" : "c6s67vGqTtPM8BNBQ", "patient_label" : "DTB-030", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 75, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.735-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-030", "site_of_metastasis" : "Lung", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2530, "end_day" : -2169 }, { "drug_name" : "Carboplatin;  Taxotere", "reason_for_stop" : "Completed Treatment", "start_day" : -2118, "end_day" : -1950 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -1677, "end_day" : -1496 }, { "drug_name" : "Carboplatin;  Taxotere", "reason_for_stop" : "Completed Treatment", "start_day" : -1192, "end_day" : -338 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -783, "end_day" : -6 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 121 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3dc" }, "patient_id" : "jxQXgykSEuSmxGgmX", "patient_label" : "DTB-031", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 49, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.736-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-031", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -514 }, { "drug_name" : "Panobinostat", "reason_for_stop" : "Adverse Event", "start_day" : -178, "end_day" : -157 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -178, "end_day" : -58 }, { "drug_name" : "MLN8237;  Docetaxel", "category" : { "$undefined" : true }, "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice", "start_day" : 5, "end_day" : 26 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3dd" }, "patient_id" : "4CH8qaxxR6a9yNkP7", "patient_label" : "DTB-032", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 77, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.738-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-032", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1162, "end_day" : -842 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1155 }, { "drug_name" : "Ipilimumab;  Placebo", "reason_for_stop" : "Adverse Event", "start_day" : -732, "end_day" : -656 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -382, "end_day" : -354 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -294, "end_day" : -251 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -236, "end_day" : -91 }, { "drug_name" : "Docetaxel", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 8, "end_day" : 119 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3de" }, "patient_id" : "p8wF7BfPEcAJpyCDF", "patient_label" : "DTB-033", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 84, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.740-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-033", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-033Pro", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -8638 }, { "drug_name" : "Flutamide;  Lupron", "reason_for_stop" : "Adverse Event", "start_day" : -6812, "end_day" : -6478 }, { "drug_name" : "Casodex;  Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -6478, "end_day" : -3890 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3159 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1698, "end_day" : -1190 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -1182, "end_day" : -999 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -968, "end_day" : -664 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : "Completed Treatment", "start_day" : -634, "end_day" : -572 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -543, "end_day" : -298 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -268, "end_day" : -117 }, { "drug_name" : "Cabazitaxel", "reason_for_stop" : "Adverse Event", "start_day" : -69, "end_day" : -47 }, { "drug_name" : { "$undefined" : true }, "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Patient Choice", "start_day" : -69, "end_day" : 134 }, { "drug_name" : "Decadron;  Cytoxan", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 9, "end_day" : 134 }, { "drug_name" : "Radium-223 chloride", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Adverse Event", "start_day" : 135, "end_day" : 247 }, { "drug_name" : "Mitoxantrone", "category" : "SOC", "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : "Adverse Event", "start_day" : 343, "end_day" : 403 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3df" }, "patient_id" : "koMFqKAPN7ZGuQynX", "patient_label" : "DTB-034", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 69, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.742-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-034", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -3260, "end_day" : -3225 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -3211 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2528, "end_day" : -2096 }, { "drug_name" : "Nilandron", "reason_for_stop" : "Adverse Event", "start_day" : -2042, "end_day" : -1910 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1910, "end_day" : -1832 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1724, "end_day" : -1462 }, { "drug_name" : "Cabozantinib", "reason_for_stop" : "Adverse Event", "start_day" : -1062, "end_day" : -890 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : { "$undefined" : true }, "start_day" : -854, "end_day" : -230 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -62, "end_day" : -12 }, { "drug_name" : "Docetaxel;  Carboplatin", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Adverse Event", "start_day" : 2, "end_day" : 44 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e0" }, "patient_id" : "D5XKmsgz65ntMTDJo", "patient_label" : "DTB-035", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 88, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.744-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-035", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Zoladex", "reason_for_stop" : "Physician Discretion", "start_day" : -3154, "end_day" : -1328 }, { "drug_name" : "Leuprolide", "reason_for_stop" : "Progressive Disease", "start_day" : -1328, "end_day" : -293 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -432, "end_day" : -37 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -293, "end_day" : 13 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true }, "start_day" : 8 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e1" }, "patient_id" : "EPaQdoyK88YEyQqvd", "patient_label" : "DTB-036", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 74, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.746-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-036", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Progressive Disease", "start_day" : -1335, "end_day" : 4 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Physician Discretion", "start_day" : -476, "end_day" : -231 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -180, "end_day" : 21 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e2" }, "patient_id" : "xfuTmCvXLxYen8oRQ", "patient_label" : "DTB-037", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 64, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.747-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-037", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -2596, "end_day" : -1505 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2585 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -1435, "end_day" : -1043 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -1043, "end_day" : -924 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -784, "end_day" : -747 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -735, "end_day" : -735 }, { "drug_name" : "Taxotere", "reason_for_stop" : "Completed Treatment", "start_day" : -672, "end_day" : -462 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1289 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -339, "end_day" : -247 }, { "drug_name" : "Xofigo", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 25, "end_day" : 109 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e3" }, "patient_id" : "yp9fWdsiN7squqRp2", "patient_label" : "DTB-038", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 77, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.749-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-038", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -2442, "end_day" : -2144 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2256 }, { "drug_name" : "Cixutumumab", "reason_for_stop" : "Progressive Disease", "start_day" : -2080, "end_day" : -16 }, { "drug_name" : "Flutamide", "reason_for_stop" : "Adverse Event", "start_day" : -3162, "end_day" : -2797 }, { "drug_name" : "Nilandron", "reason_for_stop" : "Physician Discretion", "start_day" : -2797, "end_day" : -2797 }, { "drug_name" : "Estrogen", "reason_for_stop" : { "$undefined" : true }, "start_day" : -11563, "end_day" : -2621 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 12, "end_day" : 96 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e4" }, "patient_id" : "qaAHuhPpzpmtubAt8", "patient_label" : "DTB-039", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 71, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.752-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-039", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Patient Demise", "start_day" : -1436, "end_day" : 104 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -987, "end_day" : -909 }, { "drug_name" : "Panobinostat", "reason_for_stop" : "Progressive Disease", "start_day" : -849, "end_day" : -765 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -722, "end_day" : -121 }, { "drug_name" : "Taxotere", "reason_for_stop" : "Progressive Disease", "start_day" : -115, "end_day" : 5 }, { "drug_name" : "Docetaxel;  Phenelzine", "category" : "Clinical Trial", "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Patient Demise", "start_day" : 5, "end_day" : 104 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e5" }, "patient_id" : "GGhtvTho3C3g2xYbu", "patient_label" : "DTB-040", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 57, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.754-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-040", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -119, "end_day" : -99 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -105 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -20, "end_day" : -12 }, { "drug_name" : "Cisplatin; Etoposide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 6, "end_day" : 118 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e6" }, "patient_id" : "ps8mqWJ96qF8ezHQC", "patient_label" : "DTB-041", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 71, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.755-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-041", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3176, "end_day" : -2446 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -681 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -688, "end_day" : -658 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3176, "end_day" : -2446 }, { "drug_name" : "Abiraterone", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 19 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e7" }, "patient_id" : "MCxa44g7oM7yxYcEw", "patient_label" : "DTB-042", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 64, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.761-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-042", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Zoladex;  Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -2068, "end_day" : -1762 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : { "$undefined" : true }, "start_day" : -759 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -348, "end_day" : -149 }, { "drug_name" : "Cabazitaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -76, "end_day" : -76 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Completed Treatment", "start_day" : -598, "end_day" : -456 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -98, "end_day" : -89 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 1 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e8" }, "patient_id" : "DSRzC4LZsWE3EXsay", "patient_label" : "DTB-043", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 55, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.762-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-043", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Finasteride", "reason_for_stop" : "Progressive Disease", "start_day" : -616, "end_day" : -232 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -616, "end_day" : -212 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -226 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Patient Choice", "start_day" : 6, "end_day" : 23 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3e9" }, "patient_id" : "4f2AGwwXFmS5drMu8", "patient_label" : "DTB-044", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 72, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.764-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-044", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Docetaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -486 }, { "drug_name" : "Carboplatin; Taxol", "reason_for_stop" : "Progressive Disease", "start_day" : -406 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -277 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -214 }, { "drug_name" : "CC-115", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice", "start_day" : 44, "end_day" : 86 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ea" }, "patient_id" : "z4P6GjrZfbBDwTkRE", "patient_label" : "DTB-045", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 66, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.766-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-045", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron;  Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -503 }, { "drug_name" : "Taxotere", "reason_for_stop" : "Progressive Disease", "start_day" : -161, "end_day" : -98 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : "0%-30%", "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment", "start_day" : 42, "end_day" : 121 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : "0%-30%", "bone_response" : "PD", "reason_for_stop" : "Adverse Event", "start_day" : 149, "end_day" : 210 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3eb" }, "patient_id" : "RZfyq5pqAGyfhLhjv", "patient_label" : "DTB-046", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 66, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.768-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-046", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Docetaxel", "reason_for_stop" : "Physician Discretion", "start_day" : -718, "end_day" : -718 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -547, "end_day" : 230 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1097, "end_day" : -813 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "end_day" : -957 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 236, "end_day" : 530 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ec" }, "patient_id" : "9WT8s8KxXhKheXCDy", "patient_label" : "DTB-047", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 73, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.770-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-047", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -3029, "end_day" : -3029 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2572 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -1690, "end_day" : -1430 }, { "drug_name" : "Placebo", "reason_for_stop" : "Progressive Disease", "start_day" : -1372, "end_day" : -1325 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -1253, "end_day" : -1019 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -981, "end_day" : -472 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -420, "end_day" : -161 }, { "drug_name" : "Cabazitaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -126, "end_day" : 63 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Patient Demise", "start_day" : 108, "end_day" : 264 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ed" }, "patient_id" : "MyZqz9gJt7fRqAG6a", "patient_label" : "DTB-049", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 69, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.772-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-049", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -2828, "end_day" : -1977 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1398, "end_day" : -1186 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1339 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -943 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -608, "end_day" : -562 }, { "drug_name" : "Provenge", "reason_for_stop" : "Progressive Disease", "start_day" : -489, "end_day" : -433 }, { "drug_name" : "Carboplatin;  Taxotere", "reason_for_stop" : "Progressive Disease", "start_day" : -296, "end_day" : -263 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -223 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -243, "end_day" : 1 }, { "drug_name" : "Docetaxel;  Carboplatin", "category" : "SOC", "psa_response" : ">90%", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice", "start_day" : 19, "end_day" : 124 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ee" }, "patient_id" : "Ck3AXxRFChxMuAXeE", "patient_label" : "DTB-050", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 67, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.773-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-050", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -4327, "end_day" : -4327 }, { "drug_name" : "Zoladex", "reason_for_stop" : "Physician Discretion", "start_day" : -1311, "end_day" : -618 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -611 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -589, "end_day" : -456 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -370, "end_day" : -250 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -201, "end_day" : -20 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ef" }, "patient_id" : "fuSFmqY9comJzGnbB", "patient_label" : "DTB-052", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 67, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.775-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-052", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -4760, "end_day" : -4091 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3217, "end_day" : -2357 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -3179, "end_day" : -3179 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -957 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -965, "end_day" : -538 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -461, "end_day" : -432 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -272, "end_day" : 1 }, { "drug_name" : "Mitoxantrone;  Dexamethasone;  Cabazitaxel", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "N/A", "reason_for_stop" : "Adverse Event", "start_day" : 29, "end_day" : 71 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f0" }, "patient_id" : "FFL2hnhAnZXpA23LY", "patient_label" : "DTB-053", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 75, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.776-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-053", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1059, "end_day" : -878 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Completed Treatment", "start_day" : -542, "end_day" : -512 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -542 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -311, "end_day" : -192 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -211, "end_day" : -211 }, { "drug_name" : "Taxotere;  Carboplatin", "reason_for_stop" : "Progressive Disease", "start_day" : -147, "end_day" : -35 }, { "drug_name" : "Xofigo;  Enzalutamide", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Physician Discretion", "start_day" : 1, "end_day" : 32 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f1" }, "patient_id" : "hnZ8xTPSpuJZHydH3", "patient_label" : "DTB-055", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 75, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.778-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-055", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-055Pro", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -1316, "end_day" : -1133 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -829 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -645, "end_day" : -190 }, { "drug_name" : "Docetaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -190, "end_day" : -70 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -190, "end_day" : -190 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3, "end_day" : -3 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -757 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 55, "end_day" : 114 }, { "drug_name" : "Ketoconazole", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 12, "end_day" : 56 }, { "drug_name" : { "$undefined" : true }, "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : 176, "end_day" : 176 }, { "drug_name" : { "$undefined" : true }, "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment", "start_day" : 196, "end_day" : 210 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f2" }, "patient_id" : "Y8FJEXSi7NXhEBK7y", "patient_label" : "DTB-056", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 72, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.780-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-056", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -2501, "end_day" : -2501 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1770 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -1770, "end_day" : -1739 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -675, "end_day" : -603 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Adverse Event", "start_day" : -497, "end_day" : -340 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -560, "end_day" : -523 }, { "drug_name" : "Cabazitaxel;  Custirsen", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : "PR", "reason_for_stop" : "Adverse Event", "start_day" : 96, "end_day" : 188 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "30%-50%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 225, "end_day" : 399 }, { "drug_name" : "Cyclophosphamide;  Dexamethasone", "category" : "SOC", "psa_response" : "0%-30%", "bone_response" : "N/A", "reason_for_stop" : "Other", "start_day" : 409, "end_day" : 480 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Adverse Event", "start_day" : 502, "end_day" : 506 }, { "drug_name" : { "$undefined" : true }, "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment", "start_day" : 422, "end_day" : 429 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f3" }, "patient_id" : "XH4NiATpeS2f5L3gZ", "patient_label" : "DTB-057", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 65, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.781-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-057", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Adverse Event", "start_day" : -2151, "end_day" : -2151 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Adverse Event", "start_day" : -1754, "end_day" : -1300 }, { "drug_name" : "Casodex", "reason_for_stop" : "Adverse Event", "start_day" : -1212, "end_day" : -626 }, { "drug_name" : "Lupron", "reason_for_stop" : "Physician Discretion", "start_day" : -1212, "end_day" : -1212 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -759 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -129 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 63, "end_day" : 189 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 228 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f4" }, "patient_id" : "tEWyTP24pwHoLwjrX", "patient_label" : "DTB-058", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 68, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.782-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-058", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -1573, "end_day" : -1531 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Adverse Event", "start_day" : -1316, "end_day" : -1181 }, { "drug_name" : "Leuprolide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1316 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Other", "start_day" : -845 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -763 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Other", "start_day" : -554, "end_day" : -341 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -330, "end_day" : -210 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -330 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -210, "end_day" : -146 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -110, "end_day" : -12 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -82, "end_day" : -76 }, { "drug_name" : "Mitoxantrone", "category" : { "$undefined" : true }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 9, "end_day" : 115 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f5" }, "patient_id" : "JN2YvC2f2srJCGEpP", "patient_label" : "DTB-059", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 64, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.784-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-059", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1326, "end_day" : -1326 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Completed Treatment", "start_day" : -1190, "end_day" : -994 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } }, { "drug_name" : "Flutamide", "reason_for_stop" : "Other", "start_day" : -3673 }, { "drug_name" : "Goserelin", "reason_for_stop" : "Other", "start_day" : -3673, "end_day" : -3016 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -2925, "end_day" : -2357 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -480, "end_day" : -398 }, { "drug_name" : "Mitoxantrone", "reason_for_stop" : "Completed Treatment", "start_day" : -347, "end_day" : -158 }, { "drug_name" : "Cabozantinib", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1078, "end_day" : -12 }, { "drug_name" : "Leuprolide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2925 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Adverse Event", "start_day" : -599, "end_day" : -500 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1271, "end_day" : -1265 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -831, "end_day" : -831 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -815, "end_day" : -815 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -777, "end_day" : -766 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -634, "end_day" : -628 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -129, "end_day" : -123 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1193 }, { "drug_name" : "Enzalutamide", "category" : { "$undefined" : true }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 9, "end_day" : 150 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f6" }, "patient_id" : "ZGmugdjYd3jrHFtGa", "patient_label" : "DTB-060", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 82, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.786-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-060", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] }, { "sample_label" : "DTB-060Pro", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3982 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -3982, "end_day" : -1309 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1183, "end_day" : -874 }, { "drug_name" : "Dasatinib", "reason_for_stop" : "Progressive Disease", "start_day" : -1091, "end_day" : -874 }, { "drug_name" : "Panobinostat", "reason_for_stop" : "Progressive Disease", "start_day" : -560, "end_day" : -476 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -560, "end_day" : -462 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -461, "end_day" : -14 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 15, "end_day" : 458 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f7" }, "patient_id" : "4AnJj8QDgAdWgAPdJ", "patient_label" : "DTB-061", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 68, "race" : "Asian", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.787-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-061", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -483, "end_day" : -368 }, { "drug_name" : "Goserelin", "reason_for_stop" : { "$undefined" : true }, "start_day" : -483 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -203, "end_day" : -41 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -33, "end_day" : -3 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -211, "end_day" : -205 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -127, "end_day" : -127 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -96, "end_day" : -96 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -42, "end_day" : -35 }, { "drug_name" : "Docetaxel", "category" : { "$undefined" : true }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Patient Demise", "start_day" : 26, "end_day" : 119 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f8" }, "patient_id" : "6x6ripT4CYxZMjngF", "patient_label" : "DTB-062", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 71, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.788-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-062", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -821, "end_day" : -821 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -720, "end_day" : -666 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -660, "end_day" : -471 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -660, "end_day" : -598 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -335, "end_day" : -317 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -289, "end_day" : -323 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -158, "end_day" : -50 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -292 }, { "drug_name" : "Docetaxel", "category" : "SOC", "psa_response" : "0%-30%", "bone_response" : "PD", "reason_for_stop" : "Adverse Event", "start_day" : 30, "end_day" : 175 }, { "drug_name" : "Radium-223 chloride", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : 188, "end_day" : 315 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "0%-30%", "bone_response" : "N/A", "reason_for_stop" : "Patient Demise", "start_day" : 329, "end_day" : 376 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3f9" }, "patient_id" : "Fi7nomepsaH8hTFsh", "patient_label" : "DTB-063", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 65, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.790-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-063", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] }, { "sample_label" : "DTB-063Pro", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1821 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -1821, "end_day" : -57 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -1737, "end_day" : -1680 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "50%-90%", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 55, "end_day" : 349 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 416 }, { "drug_name" : "MEK-162", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 383, "end_day" : 413 }, { "drug_name" : "Provenge", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : { "$undefined" : true }, "start_day" : 25, "end_day" : 56 }, { "drug_name" : { "$undefined" : true }, "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : "N/A", "reason_for_stop" : "Completed Treatment", "start_day" : 63, "end_day" : 91 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3fa" }, "patient_id" : "vuAQjatrvhjj36WvK", "patient_label" : "DTB-064", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 62, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.791-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-064", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3358 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2993 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -2689, "end_day" : -2324 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -2171, "end_day" : -4668 }, { "drug_name" : "Estrogen", "reason_for_stop" : "Progressive Disease", "start_day" : -924, "end_day" : -832 }, { "drug_name" : "Docetaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -744, "end_day" : -589 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -193, "end_day" : -23 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 6, "end_day" : 385 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3fb" }, "patient_id" : "8asdquHwRJMxJumT9", "patient_label" : "DTB-065", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 69, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.793-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-065", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2268 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -2042, "end_day" : -1506 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -2268, "end_day" : -1432 }, { "drug_name" : "Vandetanib", "reason_for_stop" : "Progressive Disease", "start_day" : -1385, "end_day" : -1301 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1385, "end_day" : -1301 }, { "drug_name" : "OGX-427", "reason_for_stop" : "Completed Treatment", "start_day" : -1216, "end_day" : -1007 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Completed Treatment", "start_day" : -1209, "end_day" : -1021 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -927, "end_day" : -843 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -784, "end_day" : -447 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -784, "end_day" : -448 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Other", "start_day" : -426, "end_day" : -257 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Other", "start_day" : -1810 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -221, "end_day" : -95 }, { "drug_name" : "Mitoxantrone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -81 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1981, "end_day" : -1939 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1231, "end_day" : -1231 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -900, "end_day" : -900 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -738, "end_day" : -731 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -507, "end_day" : -522 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -507, "end_day" : -501 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -238, "end_day" : -238 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -83, "end_day" : -83 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -405, "end_day" : -405 }, { "drug_name" : "Mitoxantrone", "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -81, "end_day" : 59 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3fc" }, "patient_id" : "PTX2wabKo4E3ewmam", "patient_label" : "DTB-067", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 73, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.794-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-067", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "other" : [ { "hello" : true } ] } ], "pathways" : [] }, { "sample_label" : "DTB-067Pro", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -4496, "end_day" : -4440 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1855, "end_day" : -1791 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1834, "end_day" : -1645 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1211, "end_day" : -1001 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1197 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -972, "end_day" : -119 }, { "drug_name" : "RAD001", "reason_for_stop" : "Progressive Disease", "start_day" : -972, "end_day" : -119 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -84, "end_day" : 63 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 135, "end_day" : 216 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3fd" }, "patient_id" : "RbbW8TWQRFr6nyp9G", "patient_label" : "DTB-068", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 70, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.796-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-068", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2128 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -2128, "end_day" : -2114 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -2025, "end_day" : -1972 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1661, "end_day" : -593 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -461, "end_day" : -268 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -349, "end_day" : -321 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -209, "end_day" : -31 }, { "drug_name" : "Itraconazole", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Progressive Disease", "start_day" : 78, "end_day" : 99 }, { "drug_name" : "Docetaxel;  Carboplatin", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 110, "end_day" : 201 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3fe" }, "patient_id" : "ajdqZZuLLQBqhniwY", "patient_label" : "DTB-069", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 73, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.798-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-069", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Flutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1389 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1381, "end_day" : -526 }, { "drug_name" : "OGX-427", "reason_for_stop" : "Progressive Disease", "start_day" : -650, "end_day" : -420 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -703 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Completed Treatment", "start_day" : -367, "end_day" : -174 }, { "drug_name" : "Reolysin", "reason_for_stop" : "Completed Treatment", "start_day" : -367, "end_day" : -174 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -86, "end_day" : 33 }, { "drug_name" : "Cabazitaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : 34 }, { "drug_name" : "Cabazitaxel", "category" : { "$undefined" : true }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "end_day" : 169 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc3ff" }, "patient_id" : "zmJQPBJGHjx4Mrf4H", "patient_label" : "DTB-070", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 76, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.799-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-070", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Patient Choice", "end_day" : -732 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -746, "end_day" : -697 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -360 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -391, "end_day" : -35 }, { "drug_name" : "Radium-223 chloride", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "PR", "reason_for_stop" : "Completed Treatment", "start_day" : 114, "end_day" : 179 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc400" }, "patient_id" : "Qf22huSRfLFtTKdkN", "patient_label" : "DTB-071", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 66, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.801-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-071", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Flutamide", "reason_for_stop" : "Other", "start_day" : -3580 }, { "drug_name" : "Zoladex", "reason_for_stop" : "Other", "start_day" : -3566, "end_day" : -663 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -910, "end_day" : -761 }, { "drug_name" : "Leuprolide", "reason_for_stop" : "Other", "start_day" : -663, "end_day" : -119 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -655, "end_day" : -453 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -453, "end_day" : 0 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -761, "end_day" : -655 }, { "drug_name" : "Abiraterone", "category" : { "$undefined" : true }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 154, "end_day" : 210 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc401" }, "patient_id" : "WHhmzQkpYaYPRPmx9", "patient_label" : "DTB-072", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 66, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.803-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-072", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Other", "start_day" : -2215, "end_day" : -1193 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -2033, "end_day" : -1515 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -1515 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Other", "start_day" : -1193 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -1160, "end_day" : -960 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Other", "start_day" : -903 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc402" }, "patient_id" : "hSm7skpwp8KJ37N6y", "patient_label" : "DTB-073", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 67, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.804-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-073", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] }, { "sample_label" : "DTB-073Pro", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Adverse Event", "start_day" : -1579, "end_day" : -1214 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1002 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1609, "end_day" : -1487 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1032, "end_day" : -544 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -489, "end_day" : -12 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 3, "end_day" : 60 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc403" }, "patient_id" : "KauTvtzwMmdywiRaM", "patient_label" : "DTB-074", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 76, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.805-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-074", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -5505, "end_day" : -5505 }, { "drug_name" : "Goserelin", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4531 }, { "drug_name" : "Ketoconazole;  Hydrocortisone Sodium Succinate", "reason_for_stop" : "Progressive Disease", "start_day" : -2127, "end_day" : -196 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -196 }, { "drug_name" : "Goserelin", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2120 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc404" }, "patient_id" : "fLjeCZbAQ6HnmrAYb", "patient_label" : "DTB-075", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 71, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.807-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-075", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -857 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -857, "end_day" : -674 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -430, "end_day" : -340 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Adverse Event", "start_day" : -335, "end_day" : -287 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Physician Discretion", "start_day" : -264, "end_day" : -223 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : { "$undefined" : true }, "start_day" : -279 }, { "drug_name" : "Docetaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -221, "end_day" : -116 }, { "drug_name" : "Xofigo", "reason_for_stop" : { "$undefined" : true }, "start_day" : -84 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Patient Demise", "start_day" : -30 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc405" }, "patient_id" : "EzFRr9yo6xhFiLxuj", "patient_label" : "DTB-076", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 79, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.808-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-076", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Completed Treatment", "start_day" : -5167, "end_day" : -4792 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Physician Discretion", "start_day" : -5167, "end_day" : -5006 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Other", "start_day" : -4792, "end_day" : -4427 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -4031, "end_day" : -3331 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Adverse Event", "start_day" : -3280, "end_day" : -3056 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -3241, "end_day" : -2935 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -2054, "end_day" : -1839 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Completed Treatment", "start_day" : -2054, "end_day" : -2023 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1723, "end_day" : -1401 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1807, "end_day" : -1723 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1627 }, { "drug_name" : "Flutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1117, "end_day" : -1081 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -1044, "end_day" : -775 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -775, "end_day" : -593 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -497, "end_day" : -316 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -295, "end_day" : -1 }, { "drug_name" : "Docetaxel", "category" : { "$undefined" : true }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : 12, "end_day" : 107 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc406" }, "patient_id" : "Qj96pr8FM7Q7rHTDc", "patient_label" : "DTB-077", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 70, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.810-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-077", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1098 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -435, "end_day" : -60 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -2600, "end_day" : -2600 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 8 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc407" }, "patient_id" : "jXTBoA2w7pGFbJWao", "patient_label" : "DTB-078", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 89, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.812-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-078", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1024 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Other", "start_day" : -1024, "end_day" : -901 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -871, "end_day" : -810 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -104, "end_day" : -43 }, { "drug_name" : "Xofigo", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Patient Demise", "start_day" : 20, "end_day" : 48 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc408" }, "patient_id" : "ia6n9gAnqSzxyrw9C", "patient_label" : "DTB-079", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 78, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.814-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-079", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4229 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1550, "end_day" : -1466 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -1445, "end_day" : -1193 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1193, "end_day" : -10 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 16, "end_day" : 138 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc409" }, "patient_id" : "xPunswTDMyokxRfGK", "patient_label" : "DTB-080", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 59, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.816-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-080", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] }, { "sample_label" : "DTB-080Pro", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -374 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 4, "end_day" : 275 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc40a" }, "patient_id" : "eFkcjhr24zkZ4xhgE", "patient_label" : "DTB-081", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 53, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.820-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-081", "site_of_metastasis" : "Liver", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -605, "end_day" : -288 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Other", "start_day" : -861, "end_day" : -728 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -919, "end_day" : -871 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1087 }, { "drug_name" : "Cabazitaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -124, "end_day" : 0 }, { "drug_name" : "Custirsen", "reason_for_stop" : "Progressive Disease", "start_day" : 233, "end_day" : 0 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -292, "end_day" : -189 }, { "drug_name" : "PX-866", "reason_for_stop" : "Progressive Disease", "start_day" : -330, "end_day" : -288 }, { "drug_name" : "Etoposide;  Cisplatin", "category" : { "$undefined" : true }, "psa_response" : "30%-50%", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 168, "end_day" : 92 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc40b" }, "patient_id" : "zqxoq7dZ8ocAzpMpr", "patient_label" : "DTB-082", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 62, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.822-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-082", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -947, "end_day" : 1 }, { "drug_name" : "Casodex", "reason_for_stop" : "Adverse Event", "start_day" : -956, "end_day" : -949 }, { "drug_name" : "Ipilimumab;  Provenge", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : 36, "end_day" : 145 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc40c" }, "patient_id" : "eNjraYqeFYG4j8XMC", "patient_label" : "DTB-083", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCD", "age" : 75, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.825-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-083", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -2620, "end_day" : -2620 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : 21 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -155, "end_day" : -63 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1889 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1889 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -520, "end_day" : -338 }, { "drug_name" : "Taxotere", "reason_for_stop" : "Adverse Event", "start_day" : -794, "end_day" : -794 }, { "drug_name" : "Cabazitaxel", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 56, "end_day" : 146 }, { "drug_name" : "Cytoxan", "category" : "SOC", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 149, "end_day" : 196 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc40d" }, "patient_id" : "njzpwxcbXrg9tat42", "patient_label" : "DTB-084", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 59, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.827-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-084", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1010, "end_day" : -625 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -588, "end_day" : -16 }, { "drug_name" : "Lupron", "reason_for_stop" : "Patient Choice", "start_day" : -2135, "end_day" : -2155 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1614 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "0%-30%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 7, "end_day" : 145 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc40e" }, "patient_id" : "kBvHt9C9S8sD8A6wC", "patient_label" : "DTB-085", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 74, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.828-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-085", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -158, "end_day" : -151 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -89, "end_day" : -89 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -78, "end_day" : -74 }, { "drug_name" : "Finasteride", "reason_for_stop" : "Progressive Disease", "start_day" : -2602, "end_day" : -2195 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -1802, "end_day" : -1840 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Completed Treatment", "start_day" : -2167, "end_day" : -2136 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1330 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -969, "end_day" : -791 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1100, "end_day" : -1020 }, { "drug_name" : "OGX-427", "reason_for_stop" : "Progressive Disease", "start_day" : -774, "end_day" : 79 }, { "drug_name" : "Custirsen", "reason_for_stop" : "Completed Treatment", "start_day" : -616, "end_day" : -404 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Completed Treatment", "start_day" : -607, "end_day" : -385 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -607, "end_day" : -357 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -313, "end_day" : -251 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -313 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -245, "end_day" : -14 }, { "drug_name" : "Docetaxel", "category" : { "$undefined" : true }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 2, "end_day" : 145 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc40f" }, "patient_id" : "WBJ7PDG7iYMuuzZm8", "patient_label" : "DTB-087", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 66, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.829-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-087", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Lupron", "reason_for_stop" : "Progressive Disease", "start_day" : -1806, "end_day" : -1447 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -290, "end_day" : -128 }, { "drug_name" : "Degarelix", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1043 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1806, "end_day" : -1430 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 5 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc410" }, "patient_id" : "B52qpDonZWEffJYKN", "patient_label" : "DTB-092", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 67, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.830-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-092", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -1261, "end_day" : -1261 }, { "drug_name" : "Lupron", "reason_for_stop" : "Completed Treatment", "start_day" : -1259, "end_day" : -1227 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -366, "end_day" : -31 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1059, "end_day" : -896 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -1039, "end_day" : -993 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -485 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Progressive Disease", "start_day" : 7, "end_day" : 138 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc411" }, "patient_id" : "vMKaZCjPwEae2zyPo", "patient_label" : "DTB-093", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 73, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.832-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-093", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Physician Discretion", "start_day" : 27, "end_day" : 85 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc412" }, "patient_id" : "qG7ycnpJ4x5HbofSn", "patient_label" : "DTB-094", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 65, "race" : "Black or African American", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.833-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-094", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -906, "end_day" : 0 }, { "drug_name" : "Hydrocortisone Sodium Succinate;  Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -1689, "end_day" : -1227 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -1980, "end_day" : -1689 }, { "drug_name" : "Zoladex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2142 }, { "drug_name" : "Zoladex", "reason_for_stop" : "Physician Discretion", "start_day" : -2511, "end_day" : -2446 }, { "drug_name" : "Lupron", "reason_for_stop" : "Other", "end_day" : -3090 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Progressive Disease", "start_day" : -1230, "end_day" : -925 }, { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : "SD", "reason_for_stop" : "Other", "start_day" : -30, "end_day" : 145 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc413" }, "patient_id" : "BQReq3RgPDwKhwYyg", "patient_label" : "DTB-095", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 67, "race" : "Unknown", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.834-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-095", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] }, { "sample_label" : "DTB-095Pro", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Trelstar", "reason_for_stop" : { "$undefined" : true }, "start_day" : -2705 }, { "drug_name" : "Docetaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1823, "end_day" : -1701 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -1154, "end_day" : -454 }, { "drug_name" : "Denosumab", "reason_for_stop" : { "$undefined" : true }, "start_day" : -940 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Adverse Event", "start_day" : -423, "end_day" : -270 }, { "drug_name" : "Xofigo", "reason_for_stop" : { "$undefined" : true }, "start_day" : -190 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -135 }, { "drug_name" : "Provenge", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : 32, "end_day" : 74 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc414" }, "patient_id" : "CMbtx53M6bSAbC6vT", "patient_label" : "DTB-096", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 70, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.836-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-096", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] }, { "sample_label" : "DTB-096Pro", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -332, "end_day" : -16 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -727, "end_day" : -637 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1336 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -1305, "end_day" : -879 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "PD", "reason_for_stop" : "Progressive Disease", "start_day" : 5, "end_day" : 130 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc415" }, "patient_id" : "yDd9Y5XoaCiCS4829", "patient_label" : "DTB-098", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 58, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.837-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-098", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -199, "end_day" : -171 }, { "drug_name" : "Casodex", "reason_for_stop" : "Completed Treatment", "start_day" : -219, "end_day" : -209 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -202 }, { "drug_name" : "Degarelix", "reason_for_stop" : { "$undefined" : true }, "start_day" : -233, "end_day" : -233 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 6 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc416" }, "patient_id" : "FirSTzzFCnc5XDKin", "patient_label" : "DTB-099", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 66, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.838-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-099", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -540, "end_day" : -24 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -862, "end_day" : -582 }, { "drug_name" : "Casodex", "reason_for_stop" : "Patient Choice", "start_day" : -1568, "end_day" : -1291 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3425 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -6731, "end_day" : -6731 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : "50%-90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 4 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc417" }, "patient_id" : "KyTrhrKpaTdYBHZ72", "patient_label" : "DTB-100", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UBC", "age" : 68, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.839-0700" }, "is_on_study" : true, "treatments" : [ { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -6142 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1311, "end_day" : -1226 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -605, "end_day" : -423 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1088, "end_day" : -635 }, { "drug_name" : "Degarelix", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1078 }, { "drug_name" : "Docetaxel", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1697, "end_day" : -1486 }, { "drug_name" : "Goserelin", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3552, "end_day" : -1161 }, { "drug_name" : "Flutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4396, "end_day" : -5116 }, { "drug_name" : "Goserelin", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4396, "end_day" : -4386 }, { "drug_name" : "Flutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3548, "end_day" : -3284 }, { "drug_name" : "Goserelin", "reason_for_stop" : { "$undefined" : true }, "start_day" : -6142, "end_day" : -6053 }, { "drug_name" : "Bicalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3254, "end_day" : -2060 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -5126, "end_day" : -5082 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1088 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1955, "end_day" : -1428 }, { "drug_name" : "Mitoxantrone", "category" : { "$undefined" : true }, "psa_response" : "No Decline", "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : 6, "end_day" : 29 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc418" }, "patient_id" : "ZNPG2urzb9gqdbE7q", "patient_label" : "DTB-102", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "OHSU", "age" : 85, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.841-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-102", "site_of_metastasis" : "Other", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [ { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [ { "hello" : true } ] }, { "type" : "kinase", "description" : "Kinase Activation", "signature_algorithms" : [ { "signature_algorithm_label" : "kinase_viper_v1", "signature_algorithm_report_id" : "reportidforsignaturealgorithm", "job_id" : "jobidforsignaturealgorithm", "version_number" : "1", "value_type" : "kinase_viper", "individual_signatures" : [] } ], "other" : [] } ], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -4438, "end_day" : -4410 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : "Progressive Disease", "start_day" : -2108, "end_day" : -1786 }, { "drug_name" : "Casodex", "reason_for_stop" : "Progressive Disease", "start_day" : -2820, "end_day" : -2168 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -4551 }, { "drug_name" : "Taxotere", "reason_for_stop" : "Patient Choice", "start_day" : -1772, "end_day" : -1667 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -1093, "end_day" : -930 }, { "drug_name" : "Panobinostat", "reason_for_stop" : "Adverse Event", "start_day" : -631, "end_day" : -526 }, { "drug_name" : "Custirsen", "reason_for_stop" : "Patient Choice", "start_day" : -372, "end_day" : -217 }, { "drug_name" : "Casodex", "reason_for_stop" : "Adverse Event", "start_day" : -631, "end_day" : -526 }, { "drug_name" : "Provenge", "reason_for_stop" : "Completed Treatment", "start_day" : -769, "end_day" : -733 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -6226, "end_day" : -6165 }, { "drug_name" : "Cabazitaxel", "reason_for_stop" : { "$undefined" : true }, "end_day" : -232 }, { "drug_name" : "Enzalutamide", "category" : "Clinical Trial", "psa_response" : ">90%", "bone_response" : "SD", "reason_for_stop" : { "$undefined" : true }, "start_day" : 8 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc419" }, "patient_id" : "WBHut669gk9sT23CN", "patient_label" : "DTB-104", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 82, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.842-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-104", "site_of_metastasis" : "Lymph nodes", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -1386, "end_day" : -1188 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1597, "end_day" : -997 }, { "drug_name" : "Ketoconazole", "reason_for_stop" : { "$undefined" : true }, "start_day" : -6914, "end_day" : -6809 }, { "drug_name" : "Enzalutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -454, "end_day" : 152 }, { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -869, "end_day" : -702 }, { "drug_name" : "Nilandron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3631, "end_day" : -2372 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3631 }, { "drug_name" : "Casodex", "reason_for_stop" : { "$undefined" : true }, "start_day" : -6818, "end_day" : -3631 }, { "drug_name" : "Flutamide", "reason_for_stop" : { "$undefined" : true }, "start_day" : -7177, "end_day" : -7134 }, { "drug_name" : "Abiraterone", "category" : "SOC", "psa_response" : "30%-50%", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice", "start_day" : 163, "end_day" : 218 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc41a" }, "patient_id" : "EeeHz587M8MSu5n6x", "patient_label" : "DTB-106", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 63, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.844-0700" }, "is_on_study" : false, "samples" : [ { "sample_label" : "DTB-106", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Enzalutamide", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Progressive Disease", "start_day" : -180, "end_day" : 79 }, { "drug_name" : "Xofigo", "category" : "SOC", "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -110, "end_day" : 53 } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc41b" }, "patient_id" : "m7kxAnxBNCMyvAMQM", "patient_label" : "DTB-107", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCLA", "age" : 66, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.849-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-107", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Goserelin", "reason_for_stop" : { "$undefined" : true }, "start_day" : -5156 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : "Completed Treatment", "start_day" : -1572, "end_day" : -1559 }, { "drug_name" : "Abiraterone", "reason_for_stop" : { "$undefined" : true }, "start_day" : -1200 }, { "drug_name" : "Nilutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -1953, "end_day" : -1246 }, { "drug_name" : "Ketoconazole;  Hydrocortisone Sodium Succinate", "reason_for_stop" : "Progressive Disease", "start_day" : -2687, "end_day" : -1953 }, { "drug_name" : "Flutamide", "reason_for_stop" : "Progressive Disease", "start_day" : -2800, "end_day" : -2730 }, { "drug_name" : "Docetaxel", "reason_for_stop" : "Patient Choice", "start_day" : -3146, "end_day" : -3048 }, { "drug_name" : { "$undefined" : true }, "category" : { "$undefined" : true }, "psa_response" : { "$undefined" : true }, "bone_response" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true } } ] }
{ "_id" : { "$oid" : "55a838d8f1f6a38b531dc41c" }, "patient_id" : "LfkqKXFT5vTYkAzsM", "patient_label" : "DTB-140", "study_id" : { "$oid" : "54795e11b089fea9740779e4" }, "study_label" : "prad_wcdt", "study_site" : "UCSF", "age" : 75, "race" : "White", "gender" : "M", "created_at" : { "$date" : "2015-07-16T16:06:00.850-0700" }, "is_on_study" : true, "samples" : [ { "sample_label" : "DTB-140", "site_of_metastasis" : "Bone", "sample_id" : "idofsampleinsamplescollection", "procedure_day" : 3, "signature_types" : [], "pathways" : [] } ], "treatments" : [ { "drug_name" : "Abiraterone", "reason_for_stop" : "Progressive Disease", "start_day" : -177, "end_day" : -23 }, { "drug_name" : "Sipuleucel-T", "reason_for_stop" : { "$undefined" : true }, "start_day" : -244, "end_day" : -221 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -359 }, { "drug_name" : "Degarelix", "reason_for_stop" : { "$undefined" : true }, "start_day" : -398, "end_day" : -356 }, { "drug_name" : "Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -465, "end_day" : -402 }, { "drug_name" : { "$undefined" : true }, "reason_for_stop" : { "$undefined" : true }, "start_day" : -3237, "end_day" : -3143 }, { "drug_name" : "Casodex;  Lupron", "reason_for_stop" : { "$undefined" : true }, "start_day" : -3088, "end_day" : -482 }, { "drug_name" : "Selinexor", "category" : "Clinical Trial", "psa_response" : "No Decline", "bone_response" : "N/A", "reason_for_stop" : "Patient Choice", "start_day" : 18, "end_day" : 82 } ] }
